Abingdon Health Plc (LSE: ABDX) Stock Analysis & Fundamentals | ScreenerHero

Create free account

ABDXAbingdon Health Plc

LSE · GB · Healthcare · Diagnostics & Research · abingdonhealth.com

9.750GBp0.00%Mkt Cap: 26.61M $P/E: —1d ago

Abingdon Health Plc develops, manufactures, and distributes diagnostic devices in the United Kingdom, Europe, the United States, Canada, and internationally. It operates through Contract Development, Contract Manufacturi…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

Fulgent Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap26.61M $

Enterprise Value42.93M $

Revenue (TTM)10.40M $

Gross Profit4.06M $

Net Income (TTM)-3.71M $

Revenue/Share0.0272 USD

Last Price9.750 GBp

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees129

CountryGB

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)65.00

PEG—

EV/EBITDA-11.55

EV/Revenue4.13

P/S2.56

P/B6.50

EPS (TTM)-0.01

EPS (Forward)0.00

52W Range

0.000075% of range13.00

52W High13.00 GBp

52W Low0.0000 GBp

Profitability

Gross Margin44.32%

Oper. Margin-53.88%

EBITDA Margin-35.73%

Profit Margin-40.51%

ROE-64.43%

ROA-36.67%

Growth

Revenue Growth36.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-3.46M $

CapEx (TTM)376.09K $

FCF Margin-15.34%

FCF Yield-6.00%

Net Debt-3.00M $

Net Debt/EBITDA0.81

Balance Sheet

Debt/Equity0.19

Current Ratio1.91

Quick Ratio1.73

Book Value/Sh0.0150 GBp

Cash/Share0.0090 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 GBp

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)19.00 GBp

Upside (mean)+94.9%

Target Range19.00 GBp – 19.00 GBp

# Analysts1

Ownership

Shares Out.251.08M

Float168.65M

Insiders29.20%

Institutions30.76%

Technical

SMA 5011.34 (-14.0%)

SMA 2008.161 (+19.5%)

Beta0.16

S&P 52W Chg20.25%

Avg Vol (30d)152.49K

Avg Vol (10d)68.44K

Technical Indicators

RSI (14)25.8

MACD-0.4574

MACD Signal-0.3745

MACD Hist.-0.0829

BB Upper11.91 GBp

BB Middle10.53 GBp

BB Lower9.140 GBp

BB Width26.32%

ATR (14)0.7545 GBp

Vol Ratio (20d)0.05x